A groundbreaking breast cancer detection probe, developed over 13 years by University of Western Australia doctors and engineers at OncoRes Medical, is currently undergoing trials across Australia, with hopes for a nationwide rollout. This innovative technology aims to equip surgeons with the ability to identify microscopic cancer cells remaining in the surgical cavity during operations, a capability currently lacking. Traditionally, surgeons rely on tactile feedback, leading to approximately 30% of patients requiring a second surgery due to residual cancer detected by pathologists post-excision. The probe offers a potential solution to ensure complete cancer removal in a single procedure, significantly improving patient outcomes for breast cancer, the second most commonly diagnosed cancer in Australia.